Internally Controlled Multiplex Detection and Quantification of Microbial Nucleic Acids

• US 20100041040A1
• Filed: 06/05/2009
• Published: 02/18/2010
• Est. Priority Date: 06/06/2008
• Status: Abandoned Application

• Current Assignee: Roche Molecular Systems (Roche Holding AG)
• Original Assignee: Roche Molecular Systems (Roche Holding AG)
• Inventors: Young, Karen K.Y., Sizmann, Dorothea, Guertler, Lutz, Glaubitz, Joachim, Babiel, Reiner
• Application Number:
  US12/479,643
• Publication Number:
  US 20100041040A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6888 for detection or identification of organisms
• CPC Class Codes: C12Q 2600/16 Primer sets for multiplex assays
• CPC Class Codes: C12Q 2600/166 Oligonucleotides used as internal standards, controls or normalisation probes

Abstract

The present invention relates to new methods and uses for the detection and quantification of microbial nucleic acids employing an internal quantitative reference. Preferred methods are based on the amplification of nucleic acids, preferably the polymerase chain reaction. Further provided are kits comprising components for performing said methods and uses. Moreover, an analytical system for advantageously performing the method according to the invention is disclosed.

Claims

1. A method for detecting and quantifying a microbial nucleic acid in a biological sample, comprising:

a) providing a reaction mixture, comprising;

one or more quantitative standard nucleic acids,

two or more primer pairs, each pair being specific for different sequence portions of the microbial nucleic acid from a single microorganism, and

one or more primer pairs specific for the one or more quantitative standard nucleic acids,

b) adding the biological sample to the reaction mixture,

c) performing one or more cycling steps, wherein each cycling step comprises an amplifying step, wherein the amplifying step comprises producing two or more different amplification products derived from the microbial nucleic acid, if present in the biological sample, and producing one or more amplification products derived from the one or more quantitative standard nucleic acids,

d) detecting and quantitating detectable signal or signals generated by the amplification products derived from the microbial nucleic acid, wherein the presence or absence of the detectable signal or signals generated by the amplification products derived from the microbial nucleic acid is indicative of the presence or absence of the microbial nucleic acid in the biological sample,

e) detecting and quantitating detectable signal or signals generated by the amplification products derived from the one or more quantitative standard nucleic acids, and

f) determining the quantity of the microbial nucleic acid in the biological sample by comparison of the amount of the detectable signal or signals generated by the amplification products derived from the microbial nucleic acid to the amount of the detectable signal or signals generated by the one or more amplification products derived from the one or more quantitative standard nucleic acids.

2. The method of claim 1, the reaction mixture further comprising:

two or more probes specific for the two or more different amplification products derived from the microbial nucleic acid, and

one or more probes specific for the one or more amplification products derived from the one or more quantitative standard nucleic acids.

3. The method of claim 2, further comprising:

hybridizing the two or more probes with the two or more different amplification products derived from the microbial nucleic acid, if present, and hybridizing the one or more probes with the one or more amplification products derived from the one or more quantitative standard nucleic acids,

wherein each probe is labeled with a donor fluorescent moiety and a corresponding acceptor fluorescent moiety,

detecting and measuring fluorescence resonance energy transfer (FRET) between the donor fluorescent moiety and the acceptor fluorescent moiety of the probes, wherein the presence or absence of fluorescence from the acceptor fluorescent moiety is indicative of the presence or absence of the microbial nucleic acid in the biological sample, and

determining the quantity of the microbial nucleic acid in the biological sample by comparison of the amount of the fluorescent signals generated by the two or more different amplification products derived from the microbial nucleic acid to the amount of the fluorescent signals generated by the one or more amplification products derived from the quantitative standard nucleic acids.

4. The method of claim 1, further comprising amplifying one or more of the different sequence portions of the microbial nucleic acid and the one or more quantitative standard nucleic acids with the same primer pair.

5. The method of claim 1, further comprising amplifying one or more of the different sequence portions of the microbial nucleic acid and the one or more quantitative standard nucleic acids with one or more different primer pairs.

6. The method of claim 1, wherein said detectable signal or signals generated by the amplification products derived from the microbial nucleic acid are detected using a first fluorescent dye as a detectable label for the two or more different amplification products derived from the microbial nucleic acid, and the detectable signal or signals generated by the amplification products derived from the one or more quantitative standard nucleic acids are detecting using a second, different fluorescent dye as a detectable label for the one or more amplification products derived from the quantitative standard nucleic acids.

7. The method of claim 1, further comprising using a distinct fluorescent dye as a detectable label for each of the two or more different amplification products derived from the microbial nucleic acid, and a fluorescent dye, different from those used as the detectable label for each of the two or more different amplification products derived from the microbial nucleic acid, as a detectable label for the one or more amplification products derived from the quantitative standard nucleic acids, wherein determining the quantity of the microbial nucleic acid in the biological sample comprises separately quantifying each of the two or more different amplification products derived from the microbial nucleic acid.

8. The method of claim 1, wherein exactly one quantitative standard nucleic acid is present in the reaction mixture.

9. The method of claim 1, further comprising simultaneously detecting and quantifying the microbial nucleic acid in multiple different microorganisms.

10. The method of claim 1, wherein the nucleic acid sequences of the one or more primers are at least 12 contiguous nucleotides selected from the group consisting of SEQ ID NOS:

1-16 and 21-27 and the corresponding complementary nucleic acid sequences thereof.

11. The method of claim 2, wherein the nucleic acid sequences of the two or more probes are at least 12 contiguous nucleotides selected from the group consisting of SEQ ID NOS:

17-20, 28, 29 and the corresponding complementary nucleic acid sequences thereof.

12. A kit for detecting and quantifying a microbial nucleic acid in a biological sample according to claim 1, the kit comprising:

one or more quantitative standard nucleic acids,

two or more primer pairs, each pair being specific for different sequence portions of the microbial nucleic acid from a single target microorganism, and

one or more primer pairs specific for the one or more quantitative standard nucleic acids.

13. An analytical system for performing the method according to claim 1, the system comprising:

a sample preparation module comprising a lysis buffer for providing a biological sample, and

an amplification and detection module comprising a reaction receptacle in which the method is performed.

14. The analytical system of claim 14, further comprising a transfer module for transferring the biological sample from the sample preparation module to the reaction receptacle.